Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
(Q57612974)
scientific article published on 21 August 2011
scientific article published on 21 August 2011
Language:
other details
| description | scientific article published on 21 August 2011 |
External Links
| (P356) |
10.1136/ARD.2011.152728
|
| (P698) |
21859692
|